BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2021
View Archived Issues
IL-36-gamma is a marker of enthesitis-related arthritis
Read More
Preclinical data presented on INBRX-121 as monotherapy or in combination with IO therapy regimens
Read More
Novel pan-ERR agonists can provide cardioprotection against heart failure
Read More
Plexin D1-positive extracellular vesicles as potential biomarker of polymyositis and dermatomyositis
Read More
Increased BMP-10 activity tied to disease severity in pulmonary hypertension
Read More
Assembly Biosciences patents new compounds for HBV
Read More
Chinese researchers divulge GTPase KRAS mutant inhibitors
Read More
IMMvention Therapeutix synthesizes NLRP3 inflammasome inhibitors
Read More
Shenzhen Jingtai Technology discloses new Ret inhibitors
Read More
Accutar Biotechnology describes new compounds for cancer
Read More
Promising in vivo PK and toxicity data presented for GS-3583
Read More
U.K. study illuminates value of whole genome sequencing in rare disease care
Read More
BetterLife reports first behavioral animal pharmacology data on TD-0148A
Read More
Pyramid licenses rights to MPS1 inhibitor VRN-08 from Voronoi
Read More
Researchers unveil CCN1 as a therapeutic target for rheumatoid arthritis
Read More
CRV-431 significantly decreases growth of liver tumors in mouse model of liver cancer
Read More
New mouse model allows assessment of HTT mRNA targeting compounds for Huntington's disease
Read More
Novoron secures funding to support development of NOVO-118 for spinal cord injury and MS
Read More